InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
11
T+90 hit rate
50%
T+90 mean return
+1.8%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Waddill William D., Director. Insider active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 21 reports have been recorded. Split: 0 buy · 11 sells. Total volume traded: €1.4m. History available since 3 January 2022. The latest transaction was filed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
2,416 shares@ US$66.6626.8% of flowCommon StockSEC:0001553338-25-000005
2,416 shares@ US$66.660.0013% mcap26.8% of flowCommon StockSEC:0001553338-25-000005:0
5,451 shares@ US$68.0116.9% of flowCommon StockSEC:0001553338-25-000005:1
500 shares@ US$68.531.6% of flowCommon StockSEC:0001553338-25-000005:2
4,000 shares@ US$54.2530.5% of flowCommon StockSEC:0001104659-25-025535:0
5,130 shares0Common StockSEC:0001104659-25-001435:0
16,733 shares@ US$22.9919.6% of flowCommon StockSEC:0001628280-24-052271:0
3,748 shares@ US$21.904.2% of flowCommon StockSEC:0001628280-24-051925:0
8,000 shares@ US$12.8814.3% of flowCommon StockSEC:0001104659-24-099420:0
8,000 shares@ US$12.8814.5% of flowCommon StockSEC:0001104659-24-083039:0
8,000 shares@ US$12.8814.5% of flowCommon StockSEC:0001104659-24-070420:0
12,975 shares@ US$6.0911.2% of flowCommon StockSEC:0001104659-24-030157:0
2,634 shares@ US$37.814.8% of flowCommon StockSEC:0001628280-24-001424:0
1,300 shares@ US$38.592.4% of flowCommon StockSEC:0001628280-24-001424:1
14,987 shares@ US$25.4118.5% of flowCommon StockSEC:0001628280-23-041960:0
3,200 shares@ US$30.004.8% of flowCommon StockSEC:0001209191-23-003073:0
12,000 shares@ US$8.590.0018% mcap100.0% of flowCommon StockSEC:0001104659-22-056000:0
6,400 shares0Common StockSEC:0001209191-22-002597
6,400 shares0Common StockSEC:0001209191-22-002597:0
2,100 shares@ US$64.230.0011% mcap23.2% of flowCommon StockSEC:0001209191-22-001331:0
2,100 shares@ US$64.230.0011% mcap46.3% of flowCommon StockSEC:0001209191-22-001331
21 of 21 declarations
About Waddill William D.
William D. Waddill is a Director at Arrowhead Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc. As a board member, he contributes to the governance of these companies and strategic decision-making. His experience in the pharmaceutical sector allows him to make significant contributions.
